Skip to main content
PLOS One logoLink to PLOS One
. 2022 Aug 30;17(8):e0273214. doi: 10.1371/journal.pone.0273214

Identifying putative ventilation-perfusion distributions in COVID-19 pneumonia

Haopeng Xu 1, Nayia Petousi 1, Peter A Robbins 2,*
Editor: António M Lopes3
PMCID: PMC9426945  PMID: 36040974

Abstract

Busana et al. (doi.org/10.1152/japplphysiol.00871.2020) published 5 patients with COVID-19 in whom the fraction of non-aerated lung tissue had been quantified by computed tomography. They assumed that shunt flow fraction was proportional to the non-aerated lung fraction, and, by randomly generating 106 different bimodal distributions for the ventilation-perfusion (V˙/Q˙) ratios in the lung, specified as sets of paired values {V˙i,Q˙i}, sought to identify as solutions those that generated the observed arterial partial pressures of CO2 and O2 (PaCO2 and PaO2). Our study sought to develop a direct method of calculation to replace the approach of randomly generating different distributions, and so provide more accurate solutions that were within the measurement error of the blood-gas data. For the one patient in whom Busana et al. did not find solutions, we demonstrated that the assumed shunt flow fraction led to a non-shunt blood flow that was too low to support the required gas exchange. For the other four patients, we found precise solutions (prediction error < 1x10-3 mmHg for both PaCO2 and PaO2), with distributions qualitatively similar to those of Busana et al. These distributions were extremely wide and unlikely to be physically realisable, because they predict the maintenance of very large concentration gradients in regions of the lung where convection is slow. We consider that these wide distributions arise because the assumed value for shunt flow is too low in these patients, and we discuss possible reasons why the assumption relating to shunt flow fraction may break down in COVID-19 pneumonia.

Introduction

COVID-19 pneumonia is unusual in the severity of the hypoxaemia relative to the degree of atelectasis or consolidation observed in the lung [1]. To explore gas exchange in COVID-19 pneumonia further, Busana et al. [2] enrolled 5 patients with the disease who were undergoing mechanical ventilation in an intensive care unit, who had a pulmonary artery catheter in place for clinical reasons, and for whom there was a complete set of data for gas exchange, haemodynamics and lung mechanics together with a near-contemporaneous chest CT scan.

Busana et al. sought to interpret their data in terms of the associated ventilation-perfusion (V˙/Q˙) distribution in the lung. In order to do this, it was necessary to assign a shunt fraction (the fraction of the cardiac output that passes through the lungs without coming into contact with any fresh gas) for each patient. Busana et al. assigned this shunt fraction as equivalent to the fraction of non-aerated lung tissue observed with quantitative computed tomography for each of five patients with severe COVID-19 pneumonia. This assumption is important and we refer to it henceforth as the ‘shunt fraction assumption’. The remainder of the cardiac output perfused the aerated lung tissue, and with this Busana et al. sought to find solutions to their problem in form of ventilation-perfusion (V˙/Q˙) distributions that would reproduce the arterial partial pressures of CO2 and O2 (PaCO2 and PaO2, respectively) observed in the patients.

Busana et al.’s model of gas exchange had 498 compartments that were both perfused and ventilated, with values for V˙/Q˙ ranging from between ~10−2 to ~102. Any particular V˙/Q˙ distribution is then specified as a set of paired values for ventilation and perfusion {V˙i,Q˙i}, where i is the index for the compartment. Each compartment has a single value for PaCO2 and PaO2 associated with it that is determined by its V˙/Q˙ ratio, and the compartments taken together represent the variation in PaCO2 and PaO2 across the lungs. The PaCO2 and PaO2 for the whole lung can be calculated by mixing together all of the blood leaving the compartments. Thus the putative or candidate V˙/Q˙ distributions for any particular patient are those that, when the blood is combined from all the compartments, result in PaCO2 and PaO2 values that match those of the patient.

Busana et al. used an approach of randomly generating many different V˙/Q˙ distributions to identify candidate distributions that may approximate the underlying distribution within each patient. For each patient, 106 bimodal distributions were randomly generated, based on five underlying parameters. For each distribution, an associated PaCO2 and PaO2 value were calculated. Distributions were considered as potentially acceptable solutions for the underlying V˙/Q˙ distribution of the patient if the resultant PaCO2 and PaO2 values were within 10% of the measured values.

Busana et al. found potential solutions for four out of the five patients. The predicted values for PaCO2 and PaO2 from all the potential solutions for the V˙/Q˙ distribution for each patient together with the patient’s actual PaCO2 and PaO2 are illustrated in the figure numbered six in their paper of their paper. For no patient did their approach generate any candidate V˙/Q˙ distribution where the model value for either PaCO2 or PaO2 fell within 1 mmHg of the measured value, which is a reasonable estimate for the error associated with a blood-gas measurement. Furthermore, for no patient did the cloud of potential solution points surround the patient’s measured value. Instead the cloud was always located away from the true value in the direction of higher PaCO2 and higher PaO2. It is not clear whether these features arise because of the limited accuracy of the random simulation approach or whether there are other, more fundamental factors involved.

The purpose of the present study was to improve the accuracy with which candidate V˙/Q˙ distributions could be identified. In particular we sought to replace the random simulation approach by developing a method that would allow the direct calculation of the parameter set(s) for a V˙/Q˙ distribution that would reproduce a given patient’s PaCO2 and PaO2. Three different types of V˙/Q˙ distribution were explored in increasing order of complexity: 1) the well-known three-compartment model; 2) a model with one low and one high V˙/Q˙ compartment; and 3) a continuous V˙/Q˙ distribution based on the beta distribution.

Methods

Overview

In this study, a set of paired values for ventilation and perfusion, {V˙i,Q˙i}, is referred to as a V˙/Q˙ distribution and reflects the ventilation and perfusion going to different regions (indexed by i) in the lung. A particular choice of the number of elements within {V˙i,Q˙i}, or a particular choice of the distribution of the ratios V˙i/Q˙i within the set, is referred to as a compartmental model. Also referred to as a model within this study, is a set of equations, based on mass balance and blood gas chemistry, that reflect the processes of gas exchange within the lung. When supplied with the particular inspiratory and mixed venous blood gas compositions pertaining to a patient, this model maps {V˙i,Q˙i} to an associated arterial blood gas composition. Solutions are sets {V˙i,Q˙i} for which this calculated arterial blood gas composition matches the measured arterial blood gas composition of the patient to within experimental error. In this study, the problem is to find solutions that are also consistent with additional constraints relating to the patient, in particular the value for the cardiac output (the sum of all the elements, Q˙i), the shunt flow (the value for Q˙i, for which V˙i = 0) and the measured rate of oxygen uptake.

The methods are split into three main sections. The first section is a statement of the governing equations for compartmental models of gas exchange. The second section develops a set of useful functions, based on the governing equations of the model, that map between V˙/Q˙ ratios, respiratory quotient (R) values and compartmental partial pressures for CO2 and O2 (PCO2 and PO2, respectively). The third section develops the methodology to calculate parameter sets that will reproduce the PaCO2 and PaO2 values for each of three types of compartmental model under consideration. A flow chart to illustrate the overall process is given in Fig 1. The accuracy we sought was for the model values for PaCO2 and PaO2 to be within 1 mmHg of the patient’s measured values, although in practice the errors were less that 1x10-2 mmHg or even 1x10-3 mmHg.

Fig 1. Flow chart of the overall process.

Fig 1

The flow chart illustrates the source of data, the analytic approach taken, and the expected results. FIO2, inspired O2 fraction; PaCO2 & PaO2, arterial partial pressures for CO2 and O2, respectively; Sv¯O2, O2 saturation of mixed venous blood; Q˙t, total cardiac output; Q˙nsBM, non-shunt flow from Busana et al.; CaCO2 & CaO2, arterial gas contents for CO2 and O2, respectively; R, respiratory quotient; Cv¯O2 & Cv¯CO2, mixed venous gas contents for O2 and CO2, respectively; Pv¯CO2 & Pv¯O2, mixed venous partial pressures for CO2 and O2, respectively; PB, barometric pressure; PICO2 & PIO2, inspired partial pressures for CO2 and O2, respectively; Q˙ns3c, non-shunt flow calculated for 3-compartment model; (V˙/Q˙)L, V˙/Q˙ ratio for the low V˙/Q˙ compartment; (V˙/Q˙)H, V˙/Q˙ ratio for the high V˙/Q˙ compartment; (V˙/Q˙)Lj & (V˙/Q˙)Hj, jth pair of V˙/Q˙ ratios for the low and high V˙/Q˙ compartments, respectively.

All calculations were performed in Matlab version 9.9.0. Where numerical solutions were required, Matlab’s inbuilt solvers fsolve and fminbnd were used.

Governing equations

The lung is heterogenous, with different partial pressures for alveolar CO2 and O2 occurring in different locations. One way of modelling this is to consider the lung as if it were constructed from a set of compartments, with each individual compartment having its own unique values for alveolar PCO2 and PO2. The governing equations for the model of compartmental gas exchange arise from the conservation of mass and are essentially those from the classical studies surrounding V˙/Q˙ developed by Fenn, Rahn and Otis [3, 4] and by Riley and Cournand [5, 6].

In any given compartment, the rates at which CO2, O2 and N2 enter or leave the compartment from the blood have to equal to the rates that they enter or leave from the gas phase. This yields the following equations:

V˙CO2=Q˙(Cv¯CO2CCO2)=V˙EPCO2/PBV˙IPICO2/PB, (1)
V˙O2=Q˙(CO2Cv¯O2)=V˙IPIO2/PBV˙EPO2/PB,and (2)
V˙N2=0=V˙IPIN2/PBV˙EPN2/PB. (3)

where V˙CO2, V˙O2 and V˙N2 are the compartmental rates of gas production or consumption for CO2, O2 and N2, respectively; Q˙ is perfusion of the compartment; Cv¯CO2 and Cv¯O2 are mixed venous contents of CO2 and O2, respectively; CCO2 and CO2 are the compartmental end-capillary blood contents for CO2 and O2, respectively; PCO2 and PO2 are the compartmental partial pressures for CO2 and O2, respectively; PICO2 and PIO2 are inspired partial pressures for CO2 and O2, respectively; V˙I and V˙E are inspired and expired ventilations, respectively; and PB is barometric pressure. In the gas phase, there is the additional constraint:

PB=PN2+PCO2+PO2+PH2O, (4)

where PH2O is the saturated water vapour pressure at 37 degrees C.

It is worth noting that, apart from the diffusional equilibration for CO2 and O2 between blood and gas, these equations assume that convection is completely dominant over diffusion so that diffusion within the gas (or blood) phase can be neglected. The model also assumes that, because N2 is not metabolised and does not reversibly react with blood in large quantities like CO2 and O2, the N2 exchange between blood and gas can be set to zero.

Apart from these relations, the only other one required is a model of the dissociation curves for blood that relates paired values for PCO2 and PO2 to values for blood gas contents (CCO2 and CO2). Various approaches have been adopted by different authors over time, and the current study makes use of a recent numerical model of the oxygen and carbon dioxide dissociation curves for blood [7]. In each case, the patient’s reported haemoglobin concentration was used in the model together with an assumed albumin concentration at the lower end of the normal range at 30 gm/L. The PaCO2, PaO2 and pH were then used to construct the blood model with the correct acid-base status. Standard values for electrolytes were used as described by [7] except that the plasma chloride concentration was adjusted to provide for electroneutrality. The model described in [7] is represented here by the vector function g:

c=g(p) (5)

where c = [CCO2, CO2] and p = [PCO2, PO2].

Functions

These functions are required to map between values for V˙/Q˙, values for the respiratory quotient (R), and paired values for blood gas partial pressures/ contents.

The functions require that the composition of the mixed venous blood is known, that the composition of the inspired gas is known, and that the barometric pressure is known. Busana et al. [2] provided the patients’ mixed venous oxygen saturations, but no directly measured mixed venous partial pressures or contents. In order to obtain these, we calculated a value for Cv¯O2 based on the reported haemoglobin concentration, the reported mixed venous oxygen saturation, and an estimate for the small amount of O2 physically dissolved based on an approximate value for Pv¯O2. In the absence of measured mixed venous blood gas contents, Busana et al. assumed a respiratory quotient of 0.85 for all patients. The blood gas function, g, allowed the estimation of CaCO2 and CaO2 from the reported values for PaCO2 and PaO2. From this, for each patient we estimated:

Cv¯CO2=0.85(CaO2Cv¯O2)+CaCO2. (6)

Function for mapping V˙/Q˙ to corresponding respiratory quotient, R

This section constructs a function, h, of the form:

R=h(V˙/Q˙). (7)

The function has a domain of [0,∞] and a codomain of [Rmin, Rmax], where Rmin is obtained when V˙/Q˙ = 0 and Rmax is obtained when V˙/Q˙ → ∞. To construct the function, values are required for PB, PICO2, PIO2, Cv¯CO2 and Cv¯O2. The function was derived as follows:

Applying mass balance for N2 yields:

V˙I(PIN2/PB)=V˙E(PEN2/PB), (8)

where PIN2 is the inspired N2 partial pressure and PEN2 is the expired N2 partial pressure.

Defining alveolar ventilation as the inspiratory value, V˙=V˙I, and rearranging yields:

V˙E=(PIN2/PEN2)V˙. (9)

Substitution for V˙E according to Eq 9 and defining V˙=V˙I, allows Eqs 1 & 2 to be rewritten as:

V˙CO2=Q˙(Cv¯CO2CaCO2)=(PIN2/PEN2)V˙PCO2/PBV˙PICO2/PB,and (10)
V˙O2=Q˙(CO2Cav¯O2)=V˙PIO2/PB(PIN2/PEN2)V˙PO2/PB. (11)

Rearranging each yields:

(V˙/Q˙)((PIN2/PEN2)PCO2PICO2)/PB(Cv¯CO2g(PaCO2,PO2)[1,0]T)=0,and (12)
(V˙/Q˙)(PIO2(PIN2/PEN2)PO2)/PB(g(PaCO2,PO2)[0,1]TCv¯O2)=0, (13)

where the blood gas dissociation function, g, has been used to express CaCO2 and CaO2 (Eq 5) in terms of PaCO2 and PaO2, and we assume that alveolar PCO2 and PO2 equal to PaCO2 and PaO2. In order to obtain expressions for PIN2 and PEN2, the following relationship was used:

PN2=PBPCO2PO2PH2O, (14)

where PIN2 can then be evaluated from PICO2 and PIO2, and PEN2 expressed in terms of PCO2 and PO2. These relations now allow Eq 12 and Eq 13 to be solved simultaneously for PCO2 and PO2 by use of a numerical method. Finally, a value for R can be calculated from the relationship:

R=(Cv¯CO2g(PCO2,PO2)[1,0]T)/(g(PCO2,PO2)[0,1]TCv¯O2), (15)

where the blood gas dissociation function, g, was used to calculate CCO2 and CO2 from PCO2 and PO2. Alternatively, R may be calculated from the gas phase relationships as:

R=((PIN2/PEN2)PCO2PICO2)/(PIO2(PIN2/PEN2)PO2). (16)

Function for mapping R to PCO2 and PO2

This section describes a vector-valued function, j, of the form:

p=j(R), (17)

where, as previously, p = [PCO2, PO2]. As for the function h, values need to be specified for PB, PICO2, PIO2, Cv¯CO2 and Cv¯O2. The evaluation of this function then simply involves the simultaneous numerical solution of Eq 15 and Eq 16 for PCO2 and PO2. As for the construction of function h, the expressions for PIN2 (in terms of PICO2 and PIO2) and PEN2 (in terms of PCO2 and PO2) in Eq 16 are obtained by use of Eq 14.

Calculation of the candidate V˙/Q˙ distributions

Three different types of V˙/Q˙ distribution were explored to determine whether specific parameter set(s) could be calculated for them so that they would reproduce the PaCO2 and PaO2 for each patient individually. These are each considered in increasing order of complexity under their individual sections below.

Estimation of shunt in three-compartment model

The three-compartment lung model of Riley and Cournand [5, 6] consists of just one perfused and ventilated compartment that is called the ideal compartment, together with two other compartments consisting of pure shunt (blood flow but not ventilation) and pure deadspace (ventilation but no blood flow), respectively. The model’s special theoretical importance is that for any real V˙/Q˙ distribution, no matter how complex, there always exists a corresponding three-compartment model that can exactly replicate the patient’s PaCO2 and PaO2. A particular parameter of interest is the non-shunt flow for the three-compartment model, Q˙ns3CM. This is the blood flow to the ideal compartment.

First, V˙CO2 and V˙O2 were calculated directly as:

V˙CO2=Q˙t(Cv¯CO2CaCO2),and (18)
V˙O2=Q˙t(CaO2Cv¯O2). (19)

Next, using function j, we calculated the PCO2 and PO2 of the ideal compartment of the three-compartment model, PiCO2 and PiO2, as:

[PiCO2,PiO2]=j(0.85). (20)

We then calculated the associated blood-gas contents through function g:

[CiCO2,CiO2]=g([PiCO2,PiO2]), (21)

where CiCO2 and CiO2 are blood contents of ideal compartment.

From these values, Q˙ns3CM was estimated by either of the following two relations:

Q˙ns3CM=V˙CO2/(Cv¯CO2CiCO2),or (22)
Q˙ns3CM=V˙O2/(CiO2Cv¯O2). (23)

Importantly, Q˙ns3CM forms a minimum value for the non-shunt flow, as it is all used optimally to perfuse the ideal compartment of the model. From this, the shunt flow for the three-compartment model, Q˙s3CM, can be calculated by subtracting the shunt flow from the total cardiac output, Q˙t.

The shunt fraction assumption proposed by Busana et al., Q˙sBM (subscript ‘BM’ refers to the model of Busana et al.), is not that associated with the three-compartment model, but instead is proportional to the non-aerated lung fraction as quantified by computer tomography (CT). Subtraction of Q˙sBM from Q˙t yields the non-shunt flow that perfuses the remaining aerated lung, Q˙nsBM. The distinction between Q˙nsBM and Q˙ns3CM allowed an overall efficiency for the use of the perfusion, EQ˙nsBM, for the ventilated and perfused compartments to be defined as Q˙ns3CM/Q˙nsBM. As Q˙ns3CM is the minimum possible non-shunt flow, this ratio may be seen as the ratio of the minimum-to-actual blood flow required to deliver the gas exchange, and therefore should be less than, or equal to, one. (It is also equivalent to the ratio of the actual-to-maximum O2 consumption or CO2 production that is possible with a blood flow of Q˙nsBM.) From this, it follows immediately that, if Q˙ns3CM > Q˙nsBM, then Q˙nsBM is too low to support the gas-exchange required to produce the patient’s measured PaO2 and PaCO2. This provides a basis for our test of whether V˙/Q˙ distributions exist for the shunt flows proposed by Busana et al.

Estimation of V˙/Q˙ values for model with two perfused compartments

This section explored whether a pair of V˙/Q˙ compartments, one with low V˙/Q˙, (V˙/Q˙)L, and one with high V˙/Q˙, (V˙/Q˙)H, could reproduce a patient’s values for PaCO2 and PaO2, assuming that the combined total perfusion of the two compartments was equal to Q˙nsBM, (the shunt fraction assumption) which was calculated from the non-aerated lung fraction, FNAL, as follows:

Q˙nsBM=(1FNAL)Q˙t, (24)

where the values for FNAL are those provided by Busana et al. [2]. Expressions for total V˙CO2 and V˙O2 may be written by summing the CO2 production from the low and high V˙/Q˙ compartments, and the O2 consumption from the low and high V˙/Q˙ compartments, respectively, as follows:

V˙CO2=(Q˙nsBMf)(Cv¯CO2g(j(h((V˙/Q˙)L)))[1,0]T)+(Q˙nsBM(1f))(Cv¯CO2g(j(h((V˙/Q˙)H)))[1,0]T),and (25)
V˙O2=(Q˙nsBMf)(g(j(h((V˙/Q˙)L)))[0,1]TCv¯O2)+(Q˙nsBM(1f))(g(j(h((V˙/Q˙)H)))[0,1]TCv¯O2), (26)

where f is the fraction of blood flow to the low V˙/Q˙ compartment, and (1 –f) is the fraction of blood flow to the high V˙/Q˙ compartment.

Eqs 25 and 26 have three unknown variables: (V˙/Q˙)L, (V˙/Q˙)H and f. Thus, the general approach taken was to choose a value for (V˙/Q˙)L and then solve the equations simultaneously to obtain values for (V˙/Q˙)H and f that are associated with the particular value for (V˙/Q˙)L. However, for any particular choice for (V˙/Q˙)L, in general there is no guarantee that a solution will exist.

In order to establish possible bounds for (V˙/Q˙)L within which solutions for Eqs 25 and 26 may exist, it is first worth noting that, if (V˙/Q˙)L = 0, then all gas exchange has to arise from the (V˙/Q˙)H compartment. In this scenario (V˙/Q˙)H must equal the value for the ideal compartment from the associated three-compartment model (and Q˙nsBM(1—f) = Q˙ns3CM). As (V˙/Q˙)L is increased above zero, it will start to contribute to gas exchange with a value for R that is below the overall R value for the patient. Consequently gas exchange from the (V˙/Q˙)H compartment will require a value for R above that for the overall patient. Therefore the value for (V˙/Q˙)H must increase above the that of the ideal compartment from the associated three-compartment model. This reasoning suggests that a possible maximum for (V˙/Q˙)L may arise as the value for (V˙/Q˙)H → ∞. Consequently, we first solved Eqs 25 and 26 for (V˙/Q˙)L and f under the condition (V˙/Q˙)H → ∞, and subsequently sought solutions for Eqs 25 and 26 (in terms of (V˙/Q˙)H and f) for values of (V˙/Q˙)L between 0 and this putative maximum.

Estimation of V˙/Q˙ distributions for model with multiple perfused compartments

The final step is to attempt to construct models with multiple perfused units that could replicate the gas exchange of the patient. The preceding section suggests one possible way forward is to construct them from pairs of V˙/Q˙ compartments, where each pairing has one value below and one value above the ideal V˙/Q˙, (V˙/Q˙)i. Symmetry suggests a natural pairing between the jth low, (V˙/Q˙)Lj, and the jth high, (V˙/Q˙)Hj, compartments of the form:

(V˙/Q˙)Lj/(V˙/Q˙)i=(V˙/Q˙)i/(V˙/Q˙)Hj, (27)

which, when rearranged gives:

(V˙/Q˙)Hj=((V˙/Q˙)i)2/(V˙/Q˙)Lj. (28)

Following the approach of Busana et al. [2], we constructed a set of N evenly-spaced sub-intervals on a logarithmic basis within an interval [(V˙/Q˙)i/k, (V˙/Q˙)i] for the low V˙/Q˙ units, and a further N evenly-spaced sub-intervals on a logarithmic basis within an interval [(V˙/Q˙)i, k(V˙/Q˙)i] for the high V˙/Q˙ units. We chose a value of 50 for N and 100 for k. Values for (V˙/Q˙)Lj and ((V˙/Q˙)Hj were then allocated as the (logarithmically) central values for each of the sub-intervals below and above (V˙/Q˙)i, respectively.

For each V˙/Q˙ unit, function h (Eq 7) provides the associated value for R; for each value of R, function j (Eq 17) provides the unit’s associated PCO2 and PO2; and for each pair of PCO2 and PO2 values, function g (Eq 5) provides the unit’s associated blood gas contents, CCO2 and CO2. For each pair of units, we can solve for the fractional blood flow to the lower unit, fj, in relation to the combined blood flow to both units that generates the overall R value for the patient:

R=(fj(Cv¯CO2CLCO2,j)+(1fj)(Cv¯CO2CHCO2,j))/(fj(CLO2,jCv¯O2)+(1fj)(CHO2,jCv¯O2)), (29)

where CHCO2, j and CLCO2, j are the jth pair of blood CO2 contents for the jth pair of high and low V˙/Q˙ units, respectively; and CHO2, j and CLO2,j are the jth pair of blood O2 contents for the jth pair of high and low V˙/Q˙ units, respectively.

By considering the O2 consumption per unit of blood flow for the pair of units relative to that which would occur per unit of blood flow to the ideal compartment of the three-compartment model, an efficiency for the use of the perfusion to the jth pair of units (EQ˙j) may be calculated as:

EQ˙j=(fj(CLO2,jCv¯O2)+(1fj)(CHO2,jCv¯O2))/(CiO2Cv¯O2). (30)

From this construction, any distribution that obeys the relationship:

EQ˙nsBM=j(Q˙jEQ˙j)/Q˙nsBM, (31)

where EQ˙nsBM is the overall circulatory efficiency for the patient given by Q˙ns3CM/Q˙nsBM, should reproduce the patient’s arterial blood gas values precisely.

One approach to finding solutions to Eq 31 is to apply a parameterised probability distribution over the interval containing the values for (V˙/Q˙)Lj to distribute Q˙nsBM over the pairs of values for V˙/Q˙. We chose a bounded probability function, the beta distribution, and partitioned it into N equal divisions on the interval [0,1]. The beta distribution has two shape parameters, α and β, where α>0 and β>0. For our purposes, it was convenient to reparameterize this in the form:

α=θ,and (32)
β=μθ, (33)

where μ is a constant greater than zero, a value of 10 was initially chosen, and 0 < θ < μ. This parameterisation ensured that the peak for the probability distribution gradually migrated rightwards on the interval [0,1] as θ increased. The values for Q˙j could then be written using the cumulative density function for the beta distribution, betacdf(α, β, x), as follows:

Q˙j=(betacdf(θ,(μθ),j/N)betacdf(θ,(μθ),(j1)/N))Q˙nsBM. (34)

These may be substituted into Eq 31 to yield:

EQ˙nsBM=j(betacdf(θ,(μθ),j/N)betacdf(θ,(μθ),(j1)/N))EQ˙j. (35)

Setting EQ˙nsBM equal to the overall efficiency of gas exchange for the patient, the equation could be solved for θ to provide a possible multi-compartment V˙/Q˙ distribution for the patient. Other distributions could be calculated by varying the value of μ for the beta distribution, or potentially could be obtained by employing other distributions in place of the beta distribution.

Results

Shunt flow calculation for each patient using the three-compartment model

The essential patient data from Busana et al. [2] are given in Table 1 together with the results obtained for each patient from fitting a three-compartment model to their gas exchange data. Patients 2, 3 and 5 were relatively similar in terms of their blood gases. Patient 1 had a substantially higher PaO2 than the other patients, and patient 4 had a substantially lower PaCO2 than the other patients. The PCO2 and PO2 values for the ideal compartment for each patient reflected these initial differences.

Table 1. Patient data and results from fitting three-compartment model of gas exchange.

Patient 1 2 3 4 5
Hb /g·L -1 95 100 117 86 114
Inspired gas
PICO2 /mmHg(kPa) 0.0(0.0) 0.0(0.0) 0.0(0.0) 0.0(0.0) 0.0(0.0)
PIO2 /mmHg(kPa) 641.7(85.5) 606.1(80.8) 570.4(76.0) 570.4(76.0) 427.8(57.0)
Arterial blood
PaCO2 /mmHg(kPa) 71.0(9.5) 79.0(10.5) 69.5(9.3) 42.0(5.6) 83.3(11.1)
PaO2 /mmHg(kPa) 105.0(14.0) 62.0(8.3) 65.3(8.7) 64.0(8.5) 62.5(8.3)
CaCO2 /LSTPD·L-1 0.8685 0.8148 0.7759 0.5673 0.8097
CaO2 /LSTPD·L-1 0.1299 0.1231 0.1479 0.1107 0.1395
pHa 7.390 7.310 7.360 7.430 7.290
Mixed Venous blood
Pv¯CO2 /mmHg(kPa) 79.1(10.5) 84.8(11.3) 74.7(10.0) 46.7(6.2) 89.3(11.9)
Pv¯O2 /mmHg(kPa) 38.4(5.1) 41.0(5.5) 42.5(5.7) 35.3(4.7) 42.6(5.7)
Cv¯CO2 /L STPD ·L -1 0.9019 0.8383 0.7999 0.5926 0.8346
Cv¯O2 /L STPD ·L -1 0.0906 0.0954 0.1196 0.0809 0.1102
Ideal compartment in a three-compartment model
PiCO2 /mmHg(kPa) 67.6(9.0) 71.8(9.6) 63.2(8.4) 37.3(5.0) 76.1(10.1)
PiO2 /mmHg(kPa) 572.1(76.3) 531.8(70.9) 504.9(67.3) 531.8(70.9) 348.0(46.4)
CiCO2 /LSTPD·L-1 0.8587 0.7917 0.7530 0.5479 0.7852
CiO2 /LSTPD·L-1 0.1470 0.1525 0.1749 0.1335 0.1659
Perfusion
Q˙t /L·min -1 8.060 9.490 10.400 9.450 10.550
Q˙sBM /L·min -1 3.224 3.701 3.744 2.552 2.743
Q˙nsBM /L·min -1 4.836 5.789 6.656 6.899 7.807
Q˙s3CM /L·min -1 2.447 4.897 5.079 4.086 5.001
Q˙ns3CM /L·min -1 5.613 4.593 5.321 5.364 5.549
EQ˙nsBM (1.161) 0.793 0.799 0.778 0.711

PICO2 & PIO2, inspired PCO2 & PO2, respectively; Hb, haemglobin concentration; PaCO2 & PaO2, arterial PCO2 and PO2, respectively; CaCO2 & CaO2, arterial gas contents for CO2 and O2, respectively; pHa, arterial pH; Pv¯CO2 & Pv¯O2, mixed venous PCO2 and PO2, respectively; Cv¯CO2 & Cv¯O2, mixed venous gas contents for CO2 and O2, respectively; PiCO2 & PiO2, PCO2 and PO2 for ideal compartment of three-compartment model, respectively; CiCO2 & CiO2, blood gas contents for CO2 and O2 for ideal compartment of three-compartment model, respectively; Q˙t, total cardiac output; Q˙sBM & Q˙nsBM shunt flow to non-aerated lung and corresponding non-shunt flow from Busana et al., respectively; Q˙s3CM & Q˙ns3CM shunt flow for three-compartment model of lung and corresponding non-shunt flow, respectively; EQ˙nsBM, perfusion efficiency relative to maximal value associated with three-compartment model.

In the case of patient 1, the required perfusion to the ideal compartment of the three-compartment model, Q˙ns3CM, exceeded the hypothesised value, Q˙nsBM, as obtained from the total cardiac output and fraction of non-ventilated lung (FNAL estimated from CT in Busana et al). Given that Q˙ns3CM is the minimum possible value for perfusion for the required gas exchange, this finding means that, for this particular patient, the assumption that the shunt fraction is equivalent to fraction of non-aerated lung quantified by CT cannot be valid. The true shunt fraction for this particular patient has to be below that calculated from the fraction of non-ventilated lung. For all other patients Q˙nsBM substantially exceeded Q˙ns3CM, allowing the exploration of possible V˙/Q˙ distributions to proceed. The ratio of Q˙ns3CM:Q˙nsBM is shown as an efficiency, EQ˙nsBM, for the use of the blood flow that is being used to support gas exchange, and was less than 1 for patients 2–5.

Estimation of V˙/Q˙ pairs (two perfused compartment model) when total perfusion is equal to Q˙nsBM

Figs 2 and 3 illustrate the results for estimating pairs of low and high values for V˙/Q˙ that will replicate the PaCO2 and PaO2 values for each patient. For all pairs, the numerical error between the calculated and actual values for PaCO2 and PaO2 in the patients was very low, and always < 1x10-2 mmHg. This is a very major improvement in precision (2–3 orders of magnitude) compared with the multiple random simulations approach that was employed by Busana et al, and it demonstrates that, assuming Q˙nsBM is the non-shunt blood flow for the aerated lung, there are multiple (infinite) solutions for V˙/Q˙ distributions that match the patients’ PaCO2 and PaO2 precisely. Fig 2 illustrates that as the V˙/Q˙ for the low V˙/Q˙ compartment increased, there was a progressive increase in the low V˙/Q˙ compartment’s share of total blood flow (left-axis) and a progressive rise in V˙/Q˙ for the high V˙/Q˙ compartment (right-axis). As a higher V˙/Q˙ value for the low V˙/Q˙ compartment was associated with a higher V˙/Q˙ value for the high V˙/Q˙ compartment, we calculated putative maximal values of V˙/Q˙ for the low V˙/Q˙ compartment by assuming that, in the high V˙/Q˙ compartment, the blood was maximally oxygenated and had all the CO2 removed (i.e. (V˙/Q˙)H → ∞). The maximal values for V˙/Q˙ obtained for the low V˙/Q˙ compartment in this manner were 0.060, 0.064, 0.084 and 0.078, for patients 2, 3, 4 and 5, respectively.

Fig 2. Fraction of total perfusion to the low ventilation-perfusion (V˙/Q˙) compartment and V˙/Q˙ value for high V˙/Q˙ compartment in relation to V˙/Q˙ value for low V˙/Q˙ compartment.

Fig 2

Results shown for patients 2–5. Some values off-scale for higher values of V˙/Q˙ for the low V˙/Q˙ compartment. Differences between measured and calculated arterial partial pressures for CO2 and O2 < 1x10-2 mmHg for all distributions illustrated. f, fraction of total perfusion to the low V˙/Q˙ compartment; (V˙/Q˙)L, V˙/Q˙ ratio for the low V˙/Q˙ compartment; (V˙/Q˙)H, V˙/Q˙ ratio for the high V˙/Q˙ compartment.

Fig 3. Total ventilation as a function of (V˙/Q˙)L.

Fig 3

Results shown for patients 2–5. Some values off-scale for higher values of (V˙/Q˙)L. Differences between measured and calculated arterial partial pressures for CO2 and O2 < 1x10-2 mmHg for all distributions illustrated. V˙, total ventilation.

Fig 3 illustrates the increase in the total combined ventilation to both compartments as the value for V˙/Q˙ associated with the low V˙/Q˙ compartment increased. In contrast to perfusion, where there was a fixed value for Q˙nsBM for each patient, Busana et al did not provide information to allow the specification of a fixed value for alveolar ventilation for each patient. Were such information to be available, then the monotonic increasing nature of the ventilation in Fig 3 suggests that there would be only one pair of V˙/Q˙ units that could satisfy constraints on the values for both Q˙nsBM and alveolar ventilation.

Ventilation-perfusion distributions assuming multiple perfused compartment pairs

Fig 4 illustrates a V˙/Q˙ distribution for each patient based on the beta distribution with an assumed shape parameter μ (= α + β) of 10. For each patient, the residual numerical error in the estimate for their PaCO2 and PaO2 was 10−3 mmHg or less. Fig 5 (upper and bottom left-hand panels) illustrates the effect of varying the shape parameter (μ = 5, 10, 20) on the distribution for patient 4. Higher values of μ were associated with steeper peaks and higher total overall values for ventilation. Finally, the right-hand lower panel of Fig 5 illustrates the shape of the distribution for a hypothetical healthy person breathing air with Pv¯CO2 = 46 mmHg, Cv¯O2 = 40 mmHg, PaCO2 = 40 mmHg, PaO2 = 96 mmHg, and a presumed efficiency of use for the blood of 0.987. Here the separate V˙/Q˙ peaks in the high and low V˙/Q˙ regions have been lost and the calculation has resulted in a single central peak for the V˙/Q˙ distribution.

Fig 4. Multi-compartment distributions for V˙/Q˙.

Fig 4

Results shown for patients 2–5. Distribution based on beta distribution with parameter μ = 10, as defined in Eq 33. Differences between measured and calculated arterial partial pressures for CO2 and O2 < 1x10-3 mmHg for all distributions. Q˙, perfusion; Q˙nsBM, total non-shunt perfusion where shunt fraction has been based on the non-aerated lung fraction; θ, parameter (estimated) for beta distribution as defined in Eq 32; (V˙/Q˙)i, V˙/Q˙ value for ideal compartment for three-compartment model of lung.

Fig 5. Variations in multi-compartment V˙/Q˙ distribution generated by changing parameters of the beta distribution and by changing physiological status.

Fig 5

Results for top-left, top-right, and bottom-left panels are for patient 4 with μ = 20, 10 and 5, respectively. Results for bottom right panel are for standard blood gas values for a healthy individual with μ = 10. Differences between measured and calculated arterial partial pressures for CO2 and O2 < 1x10-3 mmHg for all distributions. Q˙ns, total non-shunt blood flow.

Discussion

Busana et al. [2] reported on five patients with severe COVID-19 pneumonia; they hypothesised that the shunt blood flow within the lungs was proportional to the fraction of non-aerated lung tissue quantified by CT, and they subsequently employed a random simulation approach that identified candidate V˙/Q˙ distributions in four out of five patients that replicated the patients’ PaCO2 and PaO2 values with limited precision. The purpose of the present study was to seek higher precision solutions that would then be within the accuracy of the blood-gas data, by developing a method that enabled direct calculation of candidate V˙/Q˙ distributions without using their random simulation approach. For the patient for whom Busana et al could find no V˙/Q˙ distributions, we were able to show that the shunt flow assumption resulted in a remaining non-shunt blood flow that was simply too low to support the gas exchange required, and therefore no solutions exist. For the other four patients, we have demonstrated that multiple, indeed infinite sets, of potential V˙/Q˙ distributions exist that were capable of reproducing the patients’ PaCO2 and PaO2 values precisely. We have identified a few of these solutions, both in the form of single pairs of V˙/Q˙ compartments and in the form of distributions of multiple simultaneous pairs of V˙/Q˙ compartments.

Why the approach of Busana et al. did not lead to solutions very close to the patients’ PaCO2 and PaO2 values is not entirely clear. One possibility is that 106 randomly chosen simulations is simply an insufficient number. This may appear strange, but Busana et al. report that their distribution has 5 parameters, and if each random choice of one parameter were to be permuted with every random choice of the other, then that would only allow 16 random choices for each parameter (165 ≈ 106). While this is possible, we suspect a more likely reason is that it is difficult to design a strategy for ensuring that any random process of generating distributions provides an even remotely even coverage of possible values for PaCO2 and PaO2. Evidence of this is very clear from the figure numbered six in their paper, which is an arterial PCO2/PO2 diagram, and shows regions where the density of possible V˙/Q˙ distributions is very high, and other regions that are covered by no possible V˙/Q˙ distributions at all. The present study obviates this difficulty by showing that it is possible directly to construct putative V˙/Q˙ distributions that are guaranteed to reproduce the PaCO2 and PaO2 of individual patients based on the classical mass balance relations that have been established for gas exchange in the lung.

Busana et al. did not provide data concerning the patient’s ventilation. The simulations constructed here vary substantially in relation to total alveolar ventilation (see Fig 3). If this ventilation were known for a patient, then it should be possible to use that information to select the particular pair of high and low V˙/Q˙ compartments consistent with the patient’s gas exchange, or alternatively select the particular shape parameter for the beta distribution (μ) based on the ventilation (see Fig 5).

Experimentally, the physiological approach that comes closest to providing a V˙/Q˙ distribution for a patient is the multiple inert gas elimination technique (MIGET) developed by Wagner and West [8]. This involves infusing into a vein a range of dissolved gases and measuring their retention and excretion ratios. In relation to the present study, it is of note that a retention for a very insoluble gas in the arterial blood would effectively provide the fraction of total blood flow that is pure shunt, and an excretion for a very soluble gas would effectively provide the fraction of total ventilation that is alveolar. Therefore, using the methodology developed in the present study, such information in combination with the PCO2 and PO2 values would be sufficient to calculate directly a single pair of low and high V˙/Q˙ compartments, or alternatively calculate a single beta distribution for V˙/Q˙, that is most representative of the V˙/Q˙ distribution within a patient.

Turning from the methodology to the results, what is evident from our solutions for the V˙/Q˙ distributions from both the methods we employed (Figs 2 and 4) is that the assumption that the shunt fraction is proportional to the fraction of non-ventilated lung (proposed by Busana et al) led to compartments with extremely low estimates for V˙/Q˙. For example, the maximum possible values for V˙/Q˙ for the (V˙/Q˙)L compartment were below 0.09 for all four patients. Similarly for the beta distribution, a considerable fraction of the total non-shunt perfusion was assigned to units of very low V˙/Q˙. In relation to this, we have considerable reservations as to whether the classical theory developed in relation to V˙/Q˙ distribution is actually applicable when very low V˙/Q˙ ratios are calculated for patients who are breathing gas containing a high inspired fraction of O2, such as in these COVID-19 patients. This is because the classical theory makes no allowance for the movement of gases by diffusion other than that across the alveolar membrane. An extreme example would be apnoeic oxygenation, where the lung is motionless and the airway connected to 100% O2. Classical V˙/Q˙ theory would predict that the alveolar gases would equilibrate with venous blood and no gas exchange would occur, whereas the reality is that the N2 in the alveolar spaces diffuses away and the lung oxygenates the blood (the diffusional uptake of O2 across the alveolar membrane generates a convective flow of O2 in the airway). By way of specific example, the inspired gas for patient 2 had a PO2 of 606 mmHg. For a V˙/Q˙ of 0.05, the PN2 calculated for the low V˙/Q˙ compartment was 527 mmHg, which compares with a PN2 of 103 mmHg calculated for the high V˙/Q˙ compartment and a PN2 of 107.0 mmHg in the inspired gas. Inevitably, this will generate significant diffusion out of the low V˙/Q˙ alveolar space, both back into the airways and also into the blood stream once the PN2 of the blood has been lowered sufficiently by its exposure to lower values for PN2 associated with other, higher V˙/Q˙ compartments. Theoretically, the problem arises because Eq 13 deal only with convection, and assume that the movement of gas by diffusion within the gas phase can be neglected. Under conditions where the N2 concentration gradients in the lung are going to be very large and convection slow, such as predicted in these patients, the use of Eqs 13 is not valid.

Several limitations exist with this study. First, the analysis is limited to the five patients for whom Busana et al. were able to collect the necessary data. This number is insufficient to generalise any results to the overall patient population with any degree of certainty. Second, some starting parameters had to be estimated, for example the mixed venous concentrations and partial pressures, from measurements of mixed venous saturation. Third, the absence of any data pertaining to ventilation meant that a useful constraint on possible solutions was also missing.

In conclusion, the V˙/Q˙ distributions that arise when the shunt blood flow fraction is assumed proportional to the non-aerated lung fraction are unlikely to represent the true state of gas exchange in these severely ill COVID-19 patients. We feel a more likely interpretation of the derangements of gas exchange in these patients is that the V˙/Q˙ distributions are not as extreme as calculated by either Busana et al. or ourselves, but rather that the shunt fraction is higher than the fraction of non-aerated lung. One possible explanation may be that infection with Sars-CoV-2 impairs hypoxic pulmonary vasoconstriction (HPV), which normally would cause vasoconstriction within the non-aerated lung, limiting the blood supply to these regions. This impairment of HPV, which may well arise from direct infection and damage of the pulmonary vascular endothelium by Sars-Cov-2 [9, 10], could contribute to a shunt fraction that is greater than that expected from the amount of non-aerated (consolidated) lung. It seems to us that a simple statistic of interest would be the ratio between the shunt flow fraction calculated for the three-compartment model relative to the fraction of non-aerated lung (Q˙s3CM/Q˙sBM). This statistic could be compared with the same statistic calculated for patients suffering from non-COVID-19 ARDS. Busana et al. describe such control patients in the appendix to their paper, but there is not sufficient detail to undertake the calculation and compare the results with those for the COVID-19 patients.

Data Availability

All relevant data are within the paper.

Funding Statement

HX, China Scholarship Council (CSC)-Chinese Academy of Medical Sciences (CAMS) Oxford Institute (COI), https://www.camsoxford.ox.ac.uk/. NP, Respiratory theme, the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC) http://oxfordbrc.nihr.ac.uk/ PAR, Respiratory theme, the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC) http://oxfordbrc.nihr.ac.uk/ The views expressed are those of the authors and not necessarily those of the National Health Service (NHS), the NIHR, or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

References

  • 1.Gattinoni L, Coppola S, Cressoni M, Busana M, Rossi S, Chiumello D. COVID-19 Does Not Lead to a "Typical" Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med. 2020;201(10):1299–300. doi: 10.1164/rccm.202003-0817LE [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Busana M, Giosa L, Cressoni M, Gasperetti A, Di Girolamo L, Martinelli A, et al. The impact of ventilation-perfusion inequality in COVID-19: a computational model. J Appl Physiol (1985). 2021;130(3):865–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Fenn WO, Rahn H, Otis AB. A theoretical study of the composition of alveolar air at altitude. American Journal of Physiology. 1946;146:637–53. [DOI] [PubMed] [Google Scholar]
  • 4.Rahn H. A concept of mean alveolar air and the ventilation-blood flow relationships during pulmonary gas exchange. Am J Physiol. 1949;158(1):21–30. doi: 10.1152/ajplegacy.1949.158.1.21 [DOI] [PubMed] [Google Scholar]
  • 5.Riley RL, Cournand A. Ideal alveolar air and the analysis of ventilation-perfusion relationships in the lungs. J Appl Physiol. 1949;1(12):825–47. doi: 10.1152/jappl.1949.1.12.825 [DOI] [PubMed] [Google Scholar]
  • 6.Riley RL, Cournand A. Analysis of factors affecting partial pressures of oxygen and carbon dioxide in gas and blood of lungs; theory. J Appl Physiol. 1951;4(2):77–101. doi: 10.1152/jappl.1951.4.2.77 [DOI] [PubMed] [Google Scholar]
  • 7.O’Neill DP, Robbins PA. A mechanistic physicochemical model of carbon dioxide transport in blood. J Appl Physiol (1985). 2017;122(2):283–95. doi: 10.1152/japplphysiol.00318.2016 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Wagner PD, Salzman HA, West JB. Measurement of continuous distributions of ventilation-perfusion ratios: theory. Journal of Applied Physiology. 1974;36:588–99. doi: 10.1152/jappl.1974.36.5.588 [DOI] [PubMed] [Google Scholar]
  • 9.Ackermann M, Verleden SE, Kuehnel M, Haverich A, Welte T, Laenger F, et al. Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19. N Engl J Med. 2020;383(2):120–8. doi: 10.1056/NEJMoa2015432 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Varga Z, Flammer AJ, Steiger P, Haberecker M, Andermatt R, Zinkernagel AS, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395(10234):1417–8. doi: 10.1016/S0140-6736(20)30937-5 [DOI] [PMC free article] [PubMed] [Google Scholar]

Decision Letter 0

Adélia Sequeira

4 Nov 2021

PONE-D-21-23433Identifying putative ventilation-perfusion distributions in COVID-19 pneumoniaPLOS ONE

Dear Dr. Robbins,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Dec 10 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Adélia Sequeira, Ph.D

Academic Editor

PLOS ONE

Journal Requirements:

When submitting your revision, we need you to address these additional requirements.

1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at 

https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 

https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf

2. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. 

When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section.

Additional Editor Comments

The manuscript deals with a very interesting topic and a new mathematical model.

Based on the advice received from our reviewers, I feel that your manuscript could be reconsidered for publication should you be prepared to incorporate major revisions. When preparing your revised manuscript, you are asked to carefully consider the reviewers comments, which can be found below, and submit a list of responses to the comments.

One particular issue needs your special attention: a complete rewriting of the abstract and introduction is required in order to understand the main purpose of the paper.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: No

Reviewer #2: Partly

Reviewer #3: Yes

**********

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: N/A

Reviewer #3: N/A

**********

3. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

Reviewer #3: Yes

**********

5. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: This paper deals with the identification of ventilation-perfusion imbalances in COVID-19 pneumonia. The topic is interesting. However, the paper presents major drawbacks for which the paper cannot be accepted in the present form: it requires a full rewriting before being reconsidered.

1) One should read well down into the paper, close to the end, to understand the purpose of the paper and its goals. Basically, the paper proposes a modification of a mathematical model that is to be personalized to patients. A complete rewriting of the abstract and introduction is required.

2) Several unclear and misleading terms are used. Accuracy and existence of solutions must be properly accompanied with mathematical and numerical models, other than recast in the proper context. The identification of solutions is unclear too.

3) Model personalization and validation are not mentioned; if so, they are presented in the paper in a narrative manner that prevents comprehension of the procedures used.

4) The mathematical model is not clearly presented. The authors discuss how they arrived to the model, but then the set of equations to be solved (compartmental 0D models) are not clearly written. How are these differing from other models in literature? How is the model validated?

5) The issue of mass conservation is introduced in the abstract, but then the discussion at the end of the paper fail to highlight the reason for which this is unlikely to hold. In addition, one may find hard to believe that a physical principle in classic mechanics like mass conservation does not hold in this context.

6) The motivation to this work appears to come from drawbacks from a paper in literature by Busana et al., which is unpleased by the authors. I believe that, regardless of the pros and cons of the mentioned previous study, negative views of this work should be recast in a more constructive manner.

Specific comments for the abstract.

7) Abstract, 21 (and Introduction). Rephrase the first part of the abstract. Motivations to this paper and its content should not move from negative views on previously appeared papers. “For no patient they did obtain accurate results”. Rather, try recasting the previous work in a positive manner.

8) Abstract, 27. After accuracy of previous results is discussed, the goal of the paper is stated “to determine whether such solutions exist, and if so, to develop accurate method by which possible solutions can be identified”. What is the the analysis of solutions’ existence that is established in this paper? What does solution identification mean?

9) Abstract, 30. What does it mean that “no solution was possible”?

10) Abstract, 32. What does it mean “precise solution to the problem”?

11) Abstract, 34. In which sense are solutions “exact”?

12) Abstract, 34-35. The statement is unclear. What is the purpose of the method that is failing? Performing numerical discretization of the mathematical model? Or performing data assimilation?

13) Abstract, 36. What is the conclusions and the proposed remedy to the unlikely assumption made on mass conservation?

Reviewer #2: The paper deals with a new mathematical model to determine a ventilation-perfusion distribution able to reproduce the oxygen and Co2 partial pressure in COVID-19 patients. The authors start from a previous model and improve it, showing with their results applied to a cohort of 5 patients the improvements with respect to the previous results.

The topic of the paper is of great interest due to an attempt to better understand COVID-19 effects on ventilation and perfusion of lungs in a quantitative way. However, some remarks are due and the authors should carefully fix the following points

MAJOR REMARKS:

1. The authors refer to the work of Busana et al in terms too competitive, providing definite statements on such a work, e.g.

“… they subsequently failed to find any accurate solutions for potential …”

“… result from the hypothesis of Busana et al. are unlikely to represent the true state of gas exchange in these severely ill COVID-19 patients.”

The authors should clearly state that their model is an extension of that of Busana et al, with an improvement in some sense of the results, acknowledging the fact that the Busana model is the starting point.

2. Related to the previous point, the authors used too much strong statements about their results, e.g.:

“… we have demonstrated that no such distributions exist for their first …”

“… we have demonstrated that multiple, indeed infinite sets, of potential V̇/Q̇ distributions exist…”

It seems to me that the results of this paper are more reasonable than the ones found in Busana et al, but that there is no any validation, so I would avoid to use “demonstrate”.

3. Related to the previous point: The authors used the available data for the parameter calibration, but not for the validation, is this true? If yes, this should be clearly stated in the text

4. Also the number of cases (5) is not enough to demonstrate anything. It is noticeable to have some data after 1 year from pandemic, but the authors should again change the tone of their sentences, without any definite answer. Their results in fact “seem to show that …. “

Moreover, if I well understood, the data were obtained by Busana et al and this is another reason why the authors should refer to this paper in different terms (see point 1)

4. Methods – Overview: The journal is read by scientists with different expertise, thus I suggest to better contextualize the physical processes and the method. For example: What are the compartments? What is the pure shunt and pure deadspace? Not all the readers are familiar with this.

5. Eqns (1) and (2): I am not sure that the authors explicitly give the expression of g. In any case, Eqn (2) is useless, is the same of (1)

6. Methods: the authors should summarize all the procedure with a final algorithm or better with a flowchart, highlighting:

- the input

- how could they be obtained (measures, assumptions, …)

- the output

- their clinical relevance

7. Figures 1 and 2: It seems to me that different behaviours are experienced by Patients 2,3 vs 4,5. Please comment on this

8. Details on the numerical methods used to find solutions should be provided

9. The clinical relevance of the results should be discussed

10. Limitations and future perspective should be added

MINOR REMARKS:

1. Line 294 should be after the caption

Reviewer #3: n.a (this is not a review of the manuscript)

n.a (this is not a review of the manuscript)

n.a (this is not a review of the manuscript)

n.a (this is not a review of the manuscript)

n.a (this is not a review of the manuscript)

**********

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Reviewer #3: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Aug 30;17(8):e0273214. doi: 10.1371/journal.pone.0273214.r002

Author response to Decision Letter 0


17 Dec 2021

Reviewer #1

This paper deals with the identification of ventilation-perfusion imbalances in COVID-19 pneumonia. The topic is interesting. However, the paper presents major drawbacks for which the paper cannot be accepted in the present form: it requires a full rewriting before being reconsidered.

Comment 1: One should read well down into the paper, close to the end, to understand the purpose of the paper and its goals. Basically, the paper proposes a modification of a mathematical model that is to be personalized to patients. A complete rewriting of the abstract and introduction is required.

Response to comment 1: We have rewritten the abstract and introduction following this comment. We hope we have clarified the purpose of the paper much earlier in the text.

Comment 2: Several unclear and misleading terms are used. Accuracy and existence of solutions must be properly accompanied with mathematical and numerical models, other than recast in the proper context. The identification of solutions is unclear too.

Response to comment 2: We have now specified what is meant by accuracy and existence of solutions so as to make these terms clear.

Comment 3: Model personalization and validation are not mentioned; if so, they are presented in the paper in a narrative manner that prevents comprehension of the procedures used.

Response to comment 3: The general structure of the compartmental model is the same for each patient, but the parameters distributing blood flow and ventilation are personalized for each patient. We agree that this was not fully clear in the original manuscript and have now re-structured the Methods to separate the governing equations of the compartmental model from the personalization of the distributions.

Comment 4: The mathematical model is not clearly presented. The authors discuss how they arrived to the model, but then the set of equations to be solved (compartmental 0D models) are not clearly written. How are these differing from other models in literature? How is the model validated?

Response to comment 4: This is fair comment, and we have restructured the Methods to clarify this. The underlying compartmental model, based on mass balance, is longstanding, widely accepted and has been used by many investigators. Apart from details such as the number of compartments and the detailed form of the blood-gas dissociation curves, the model we used was essentially the same as that of Busana et al. The difference between the two papers is essentially how you personalize the distributions for individual patients.

The issues around validation in this area are much harder. We can show that a distribution is a candidate distribution for an individual, in the sense that it reproduces the patient’s arterial PCO2 and PO2. In general, however, there is always an infinite number of candidate distributions, whereas there can only be one physical distribution pertaining in the lungs. What does tend to be common amongst a set of candidate distributions are certain qualitative features, such as their overall width or the number of their peaks. Common between Busana et al and our manuscript are the extraordinarily wide distributions seen with the four patients in whom there are solutions.

Comment 5: The issue of mass conservation is introduced in the abstract, but then the discussion at the end of the paper fail to highlight the reason for which this is unlikely to hold. In addition, one may find hard to believe that a physical principle in classic mechanics like mass conservation does not hold in this context.

Response to comment 5: Sorry. This has been misunderstood. Our point was actually the other way around, namely a result that violates a fundamental principle of classic mechanics means there is something wrong with the assumptions that generated it (NOT the assumptions of classical mechanics), here the assumption of the shunt fraction value. We have re-written this point.

Comment 6: The motivation to this work appears to come from drawbacks from a paper in literature by Busana et al., which is unpleased by the authors. I believe that, regardless of the pros and cons of the mentioned previous study, negative views of this work should be recast in a more constructive manner.

Response to Comment 6: Thank you. We are glad that you flagged this because it was not intended. Busana et al have obtained patient data during the pandemic in a manner that has been remarkably hard to do. They should be commended for it. We have checked and, if necessary, rephrased our references to the Busana et al paper in the manuscript.

Comment 7: Abstract, 21 (and Introduction). Rephrase the first part of the abstract. Motivations to this paper and its content should not move from negative views on previously appeared papers. “For no patient they did obtain accurate results”. Rather, try recasting the previous work in a positive manner.

Response to Comment 7: Agreed. We have re-written this.

Comment 8: Abstract, 27. After accuracy of previous results is discussed, the goal of the paper is stated “to determine whether such solutions exist, and if so, to develop accurate method by which possible solutions can be identified”. What is the the analysis of solutions’ existence that is established in this paper? What does solution identification mean?

Response to Comment 8: Busana et al have assumed that the shunt flow fraction was proportional to the non-aerated lung fruction, and calculated this from CT imaging. Using this assumed shunt flow fraction as given by Busana et al (and the non-shunt fraction calculated from this by subtracting from cardiac output), we used the three-compartment model to investigate whether there exist V̇/Q̇ distributions for the non-shunt part of the lung that can produce the measured arterial PCO2 and PO2. (this is what we mean by solutions’ existence). This model’s theoretical importance is that for any real V̇/Q̇ distribution, no matter how complex, there always exists a corresponding three-compartment model that can exactly replicate the patient’s PaCO2 and PaO2. Using the well established three-compartment model one can calculate the maximum physiologically possible shunt fraction (Q̇s3CM) and the minimum physiologically possible non-shunt fraction (Q̇ns3CM) for each patient. For patient 1, the assumption that shunt flow fraction was proportional to the non-aerated lung fruction cannot hold, as this non-shunt flow fraction by Busana et al (Q̇nsBM) is too low, lower than the minimum possible (Q̇ns3CM), to be able to support gas-exchange to produce the patient’s PCO2 and PO2: so no solution exists (no V/Q distribution) with this assumption. For the other patients, solutions are possible with this assumed shunt and non-shunt fraction (derived from imaging), but we wanted to find a method that provides more accurate solutions, i.e. V/Q distributions that produce arterial PCO2 and PO2 that are within the measurement error of the blood gas analyser (which we take as a maximum error of 1 mmHg) (this is what is meant by solution identification).

Comments 9, 10 and 11: Abstract, 30. What does it mean that “no solution was possible”; Abstract, 32. What does it mean “precise solution to the problem”? Abstract, 34. In which sense are solutions “exact”?

Response to Comments 9, 10 and 11: We have revised the abstract to address these issues. The meanings were:.

No solution was possible: no parameterization of the model of V/Q distribution exists that can reproduce the arterial PCO2, and PO2. (This occurs for patient 1 where the specified total blood flow is simply too small to deliver the required gas exchange.)

Precision of the solution: defined in terms of the residuals for the arterial PCO2 and PO2. This is the difference between the patient’s measured data and the predicted values from the model. We aim for a precision that is within that reasonably associated with the blood gas analyser.

Exact solution: we have removed this term because all solutions require a degree of numerical estimation.

Comment 12: Abstract, 34-35. The statement is unclear. What is the purpose of the method that is failing? Performing numerical discretization of the mathematical model? Or performing data assimilation?

Response to Comment 12: The classical equations referred to here model convective transport of gases to and from well mixed compartments, and assume that diffusion can be neglected (apart from equilibration across the alveolar membrane). This assumption is reasonable under most conditions. However, the high inspired PO2 in these patients coupled with the extraordinarily wide V/Q ratios will create certain regions of the lung where convective tramsport in the gas phase is very slow, but at the same time where very large concentration gradients are predicted to persist. Under these conditions, we think the assumption that diffusion can be neglected breaks down and the model is no longer valid.

Comment 13: Abstract, 36. What is the conclusions and the proposed remedy to the unlikely assumption made on mass conservation?

Response to Comment 13: See response to comment 5. Fundamentally, we think the shunt flow assumption is not sufficiently accurate.

Reviewer #2

Comment 1: The authors refer to the work of Busana et al in terms too competitive, providing definite statements on such a work, e.g.

“… they subsequently failed to find any accurate solutions for potential …”

“… result from the hypothesis of Busana et al. are unlikely to represent the true state of gas exchange in these severely ill COVID-19 patients.”

The authors should clearly state that their model is an extension of that of Busana et al, with an improvement in some sense of the results, acknowledging the fact that the Busana model is the starting point.

Response to comment 1: Sorry. We are glad the reviewer makes this point as it really wasn’t intended. Busana et al should be congratulated for managing to obtain these data during the course of the pandemic. We have checked the wording and changed where appropriate. We have also clarified that what we set out to achieve was an alternative approach to Busana et al’s multiple simulation approach that could provide a direct calculation of parameterisations that should reproduce a patient’s arterial PCO2 and PO2.

Comment 2. Related to the previous point, the authors used too much strong statements about their results, e.g.:

“… we have demonstrated that no such distributions exist for their first …”

“… we have demonstrated that multiple, indeed infinite sets, of potential V̇/Q̇ distributions exist…”

It seems to me that the results of this paper are more reasonable than the ones found in Busana et al, but that there is no any validation, so I would avoid to use “demonstrate”.

Response to comment 2: We don’t completely agree with the reviewer here.

Busana et al found no possible solutions for their first patient. We use the three-compartment model to show that the postulated blood flow to the aerated lung is simply too low to support the gas exchange required – there is no solution to the problem (and therefore the starting assumptions concerning shut flow have to be wrong).

For the second statement, the key word is ‘potential’ (or candidate) distributions because they do reproduce the patient’s arterial PCO2 and PO2. However, we completely agree with the reviewer re: validation and have adjusted the text accordingly.

Comment 3. Related to the previous point: The authors used the available data for the parameter calibration, but not for the validation, is this true? If yes, this should be clearly stated in the text

Response to comment 3: Yes, that is completely correct. Furthermore, we argue that the extraordinarily-wide distributions are unlikely to exist in these patients given their very high inspired PO2. Thus, if there were some way of validating these results experimentally, we would expect the validation to fail. We think the problem resides with the ‘shunt flow assumption’, as covered in the Discussion.

Comment 4. Also the number of cases (5) is not enough to demonstrate anything. It is noticeable to have some data after 1 year from pandemic, but the authors should again change the tone of their sentences, without any definite answer. Their results in fact “seem to show that …. “

Moreover, if I well understood, the data were obtained by Busana et al and this is another reason why the authors should refer to this paper in different terms (see point 1)

Response to comment 4: Whilst we can demonstrate things as they apply to individual patients, we agree with the reviewer that 5 patients are too few from which to draw generalized conclusions in relation to the patient population as a whole. We have checked the manuscript to ensure any generalizations have that caveat clearly stated. We also agree with the second point (see our response to point 1).

Comment 5. Methods – Overview: The journal is read by scientists with different expertise, thus I suggest to better contextualize the physical processes and the method. For example: What are the compartments? What is the pure shunt and pure deadspace? Not all the readers are familiar with this.

Response to comment 5: This is a very fair comment. We have revised the manuscript to include those definitions, but also more generally, we now start the methods with a description of the compartmental model on which this study is based.

Comment 6. Eqns (1) and (2): I am not sure that the authors explicitly give the expression of g. In any case, Eqn (2) is useless, is the same of (1)

Response to comment 6: No we don’t give an explicit expression for g. In this study, we use quite a detailed mathematical model of the blood, which involves the simultaneous solution of four non-linear equations for the plasma H+ concentration, the intra-erythrocytic H+ concentration, the permeant strong ion difference in the plasma and the permeant strong ion difference in the red cells. These values are then substituted into other equations to get the blood CO2 and O2 contents. If we try to set this all out here (apart from anything else, there are 50-100 chemical constants), it will serve to confuse rather than help. It is better just to give the reference here (O’Neil at al) so that the interested reader can follow it up. Other readers only need to know what it is doing in order to follow the paper.

We agree equation 2 was probably unnecessary – the only points we were trying to make were that the inverse function exists (i.e. the function is both injective and surjective) and that it is possible to use it in calculations.

Comment 7. Methods: the authors should summarize all the procedure with a final algorithm or better with a flowchart, highlighting:

- the input

- how could they be obtained (measures, assumptions, …)

- the output

- their clinical relevance

Response to comment 7: This is an excellent idea and we have now introduced a flowchart into the Methods section.

Comment 8. Figures 1 and 2: It seems to me that different behaviours are experienced by Patients 2,3 vs 4,5. Please comment on this.

Response to comment 8: There are indeed some quantitative differences, and of course the patients differ in their arterial blood gases and the level of inspired O2 that they are receiving (table 1). However, qualitatively the results are similar. They are all monotonic increasing functions and the solutions are all confined to exceptionally low values for V/Q.

Comment 9. Details on the numerical methods used to find solutions should be provided

Response to comment 9: We used the in-built equation solvers in Matlab (there is nothing particularly tricky about the solutions). We have added this point to the methods and referred to the particular solvers that were employed.

Comment 10. The clinical relevance of the results should be discussed.

Response to comment 10: We have added a section in the Discussion about the results’ clinical relevance.

Comment 11. Limitations and future perspective should be added

Response to comment 11: A section on limitations and future perspective has been added in the Discussion.

Comment 12. Line 294 should be after the caption.

Response to comment 12: Done.

Attachment

Submitted filename: response_to_reviewers_par_17Dec_CLEAN.docx

Decision Letter 1

António M Lopes

17 Feb 2022

PONE-D-21-23433R1Identifying putative ventilation-perfusion distributions in COVID-19 pneumoniaPLOS ONE

Dear Dr. Robbins,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Mar 27 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

António M. Lopes, PhD

Academic Editor

PLOS ONE

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: Partly

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: Yes

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: The paper improved after a significant revision that partially incorporated the major and minor questions. I think the paper has merit, even if some major points persist and must be thoroughly addressed.

I am very confused by the use of the words “solution”, “model”, and “problem”. Mathematically speaking, a solution is a value, number, function, etc… that fulfill the conditions set by equations. Here, I find very hard to understand which are the equations to be solved (models and problems) and which variables are the solutions by reading through the text. Figure 1 is adding confusion rather than giving a clear picture of the problems/equations and solutions searched for. What is meaning that a “solution is not possible”? I also find very difficult to identify data and solutions (?) in the models.

The concept of “distribution” should be introduced and carefully presented. If I understand correctly, this work revolves around the idea of calculating such distribution instead of a sort of “trial and error” approach by Busana et al., who explore the space of plausible parameters to identify a plausible combination of these ones. Can this distribution interpreted instead as a combination of values?

118: “conservation of matter”. Shouldn’t be conservation of mass instead? Here, we are not working in the framework of relativistic mechanics, but of classical mechanics.

150: Eq. (5). g is not defined, if not much later in the text. Similarly for other mathematical notation.

Equations are numbered in round brackets (XY). However, in the text they are referred to as Eq XY. Instead, bibliographic references are cited in round brackets (in place of more common squared brackets), which is adding confusion to the “Method” section.

356-365: are these part of the table caption?

Reviewer #2: It is hard to evaluate the changes made by the authors. They should clearly indicate in their answers the number of pages and lines where changes have been made and, possibly, indicate in colours such changes in the text

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Aug 30;17(8):e0273214. doi: 10.1371/journal.pone.0273214.r004

Author response to Decision Letter 1


9 Mar 2022

Submitted title

Identifying putative ventilation-perfusion distributions in COVID-19 pneumonia

Respond to reviewers’ comments

Reviewer #1

The paper improved after a significant revision that partially incorporated the major and minor questions. I think the paper has merit, even if some major points persist and must be thoroughly addressed.

Comment 1

I am very confused by the use of the words “solution”, “model”, and “problem”. Mathematically speaking, a solution is a value, number, function, etc… that fulfill the conditions set by equations. Here, I find very hard to understand which are the equations to be solved (models and problems) and which variables are the solutions by reading through the text. Figure 1 is adding confusion rather than giving a clear picture of the problems/equations and solutions searched for. What is meaning that a “solution is not possible”? I also find very difficult to identify data and solutions (?) in the models.

Response to comment 1

Thank you – this is very helpful comment to guide further revision. We have added a paragraph at the beginning of the Methods to define the terms ‘solution’, ‘model’ and ‘problem’.

A solution is a set of paired values for ventilation and perfusion {Vi, Qi}, that will result in calculated values for arterial PCO2 and PO2 that, to within experimental error, match the measured values from the patient. We illustrate solutions in the figures. The meaning of a ‘solution is not possible’ is that, after applying constraints relating to the patient, there are no sets {Vi, ,Qi} that form a solution to the problem. This can arise if one or more of the constraints is wrong.

Comment 2

The concept of “distribution” should be introduced and carefully presented. If I understand correctly, this work revolves around the idea of calculating such distribution instead of a sort of “trial and error” approach by Busana et al., who explore the space of plausible parameters to identify a plausible combination of these ones. Can this distribution interpreted instead as a combination of values?

Response to comment 2

We have added a definition of distribution in the paragraph at the start of the Methods. Busana et al do not state what their parameters are, but basically their parameters are used to generate the ‘ V/Q distribution’, which is the set of paired values {Vi, Qi}. The number of paired values in this set can be varied. We explore the three-compartment model of the lung – which has three pairs of values in this set (and has a very important place in the development of theory around gas exchange in the lung), a four-compartment model of the lung, and a ‘multi’-compartment model of the lungs, where the number of Vi, Qi pairs is very much higher and where it is really being used as a computational approximation to a continuous distribution (where the pairs of values Vi, Qi in the set {Vi, Qi} would be infinite).

So the answer to your question is yes. The distribution is the set {Vi, Qi}.

Comment 3

118: “conservation of matter”. Shouldn’t be conservation of mass instead? Here, we are not working in the framework of relativistic mechanics, but of classical mechanics.

Response to comment 3

We have changed this.

Comment 4: 150: Eq. (5). g is not defined, if not much later in the text. Similarly for other mathematical notation.

Response to comment 4

As indicated in the preceding paragraph, g is a function that represents the blood gas model of reference 7. To make this clearer, we have now added the reference in the sentence immediately preceding equation 5.

Comment 5

Equations are numbered in round brackets (XY). However, in the text they are referred to as Eq XY. Instead, bibliographic references are cited in round brackets (in place of more common squared brackets), which is adding confusion to the “Method” section.

Response to comment 5

We have revised the manuscript so that the citations now appear in the text in squared brackets.

Comment 6

356-365: are these part of the table caption?

Response to comment 6

Yes, that is correct.

Reviewer #2

It is hard to evaluate the changes made by the authors. They should clearly indicate in their answers the number of pages and lines where changes have been made and, possibly, indicate in colours such changes in the text.

Response to reviewer #2

Our apologies for this. We used the track changes feature to highlight all the text that had changed, but there was so much of it, and so much editing, that the end result was a bit of a mess. The changes are much clearer in this second revision.

Attachment

Submitted filename: response_to_reviewers_08032022.docx

Decision Letter 2

António M Lopes

11 May 2022

PONE-D-21-23433R2

Identifying putative ventilation-perfusion distributions in COVID-19 pneumonia

PLOS ONE

Dear Dr. Robbins,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

You may see that reviewer 2 is still unclear regarding the changes made to the mansucript as a result of their comments provided in the decision letter dated November 4th 2021. We appreciate that while in the rebuttal letter following the first round of review, you have provided a response to every comment made by this reviewer, however it is not clear the changes made to the mansucript text as a result of their feedback.During this round of revision, we suggest explicitly referring to what as changed in the revised version of the mansucript when compared to the original submitted mansucript (using line numbers if possible) to support your responses to the reviewers 2 comments. This will help the reviewers and Academic Editor in re-evaluating your mansucript.

Please submit your revised manuscript by Jun 24 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

Please include the following items when submitting your revised manuscript:

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.

  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.

  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols.

We look forward to receiving your revised manuscript.

Kind regards,

Lucinda Shen 

Staff Editor 

on behalf of 

António M. Lopes, PhD

Academic Editor

PLOS ONE

Additional Editor Comments:

The authors should pay attention to the comments of reviewer #2.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #1: (No Response)

Reviewer #2: (No Response)

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #1: Partly

Reviewer #2: No

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: N/A

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: (No Response)

Reviewer #2: No

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #1: (No Response)

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #1: Response to comment 1

Thank you – this is very helpful comment to guide further revision. We have added a paragraph at the beginning of the Methods to define the terms ‘solution’, ‘model’ and ‘problem’. A solution is a set of paired values for ventilation and perfusion {Vi, Qi}, that will result in calculated values for arterial PCO2 and PO2 that, to within experimental error, match the measured values from the patient. We illustrate solutions in the figures. The meaning of a ‘solution is not possible’ is that, after applying constraints relating to the patient, there are Response to Reviewers no sets {Vi, ,Qi} that form a solution to the problem. This can arise if one or more of the constraints is wrong.

>>> This must be made very clear from the beginning, that is from the abstract.

Response to comment 2

We have added a definition of distribution in the paragraph at the start of the Methods. Busana et al do not state what their parameters are, but basically their parameters are used to generate the ‘ V/Q distribution’, which is the set of paired values {Vi, Qi}. The number of paired values in this set can be varied. We explore the three-compartment model of the lung – which has three pairs of values in this set (and has a very important place in the development of theory around gas exchange in the lung), a four-compartment model of the lung, and a ‘multi’-compartment model of the lungs, where the number of Vi, Qi pairs is very much higher and where it is really being used as a computational approximation to a continuous distribution (where the pairs of values Vi, Qi in the set {Vi, Qi} would be infinite). So the answer to your question is yes. The distribution is the set {Vi, Qi}.

>>> Also this must be very clear from the beginning of the paper.

>>> I recommend to further ease negative views on the paper of Busana et al. (like “failed to find any solution”, abstract line 29)

Reviewer #2: I cannot find the answers to my remarks. IN previous submission, the changes in the text were missing, now the answers are missing. It is difficult to evaluate the improvement of the paper

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step.

PLoS One. 2022 Aug 30;17(8):e0273214. doi: 10.1371/journal.pone.0273214.r006

Author response to Decision Letter 2


7 Jul 2022

RESPONSE TO REVIEWERS’ COMMENTS (3rd REVISION)

Reviewer #1

Comment 1

‘Thank you – this is very helpful comment to guide further revision……’

>>> This must be made very clear from the beginning, that is from the abstract.

Response to comment 1

We have now included these points in the abstract to the extent that it is possible while still remaining within the tight word limit required.

Change R2 Lines 23 - 26 ‘They assumed that the shunt flow fraction was proportional to the non-aerated lung fraction, and, by randomly generating 106 different bimodal distributions for blood flow, sought to identify ventilation-perfusion (V̇/Q̇) distributions for the aerated element of the lung that would generate the observed arterial partial pressures of CO2 and O2 (PaCO2 and PaO2¬). ’

To R3 Lines 22 - 26 ‘They assumed that shunt flow fraction was proportional to the non-aerated lung fraction, and, by randomly generating 106 different bimodal distributions for the ventilation-perfusion (V̇/Q̇) ratios in the lung, specified as sets of paired values {V̇i, Q̇i}, sought to identify as solutions those that generated the observed arterial partial pressures of CO2 and O2 (PaCO2 and PaO2¬).’

Comment 2

‘We have added a definition of distribution in the paragraph……’

>>> Also this must be very clear from the beginning of the paper.

Response to comment 2

We have now included these points within the introduction to the paper.

Insert R3 Lines 57 - 59 ‘Any particular V̇/Q̇ distribution is then specified as a set of paired values for ventilation and perfusion {V̇i, Q̇i}, where i is the index for the compartment.

Comment 3

>>> I recommend to further ease negative views on the paper of Busana et al. (like “failed to find any solution”, abstract line 29)

Response to comment 3

We have removed the word ‘failed’ in case it is seen as pejorative.

Change R2 Line 29 ‘For the one patient in whom Busana et al. failed’

To R3 Line 29 ‘For the one patient in whom Busana et al. did not find solutions’.

Reviewer #2

Comment 1

I cannot find the answers to my remarks. IN previous submission, the changes in the text were missing, now the answers are missing. It is difficult to evaluate the improvement of the paper

Response to comment 1

We appreciate that our use of the ‘track changes’ feature of Word to identify where changes had been made was not very successful. For this revision, we provide a compilation of all the reviewers’ (both reviewer 1 and reviewer 2) prior comments at each stage of the review process, together with all of our responses. Within this compilation, we have inserted, for each comment, a reference in red to the line numbers of the original manuscript where changes were made, together with a reference in red the line numbers where the changes are now to be found in the current (R3) version of the manuscript. We hope this is helpful.

RESPONSE TO REVIEWERS (1st REVISION)

Reviewer #1

This paper deals with the identification of ventilation-perfusion imbalances in COVID-19 pneumonia. The topic is interesting. However, the paper presents major drawbacks for which the paper cannot be accepted in the present form: it requires a full rewriting before being reconsidered.

Comment 1

One should read well down into the paper, close to the end, to understand the purpose of the paper and its goals. Basically, the paper proposes a modification of a mathematical model that is to be personalized to patients. A complete rewriting of the abstract and introduction is required.

Response to comment 1

We have rewritten the abstract and introduction following this comment. We hope we have clarified the purpose of the paper much earlier in the text.

Remove Original Lines 20 - 38 Old Abstract

Replace with R3 Lines 20 - 37 New Abstract.

Remove Original Lines 40 - 73 Old Introduction

Replace with R3 Lines 39 - 87 New Introduction.

Comment 2

Several unclear and misleading terms are used. Accuracy and existence of solutions must be properly accompanied with mathematical and numerical models, other than recast in the proper context. The identification of solutions is unclear too.

Response to comment 2

We have now specified what is meant by accuracy and existence of solutions so as to make these terms clear.

Insert R3 Lines 111 - 113 ‘The accuracy we sought was for the model values for PaCO2 and PaO2 to be within 1 mmHg of the patient’s measured values, although in practice the errors were less that 1x10-2 mmHg or even 1x10-3 mmHg’.

Insert R3 Lines 260 - 263 ‘From this, it follows immediately that, if Q̇ns3CM > Q̇nsBM, then Q̇nsBM is too low to support the gas-exchange required to produce the patient’s measured PaO2 and PaCO2. This provides a basis for our test of whether V̇/Q̇ distributions exist for the shunt flows proposed by Busana et al.’.

Comment 3

Model personalization and validation are not mentioned; if so, they are presented in the paper in a narrative manner that prevents comprehension of the procedures used.

Response to comment 3

The general structure of the compartmental model is the same for each patient, but the parameters distributing blood flow and ventilation are personalized for each patient. We agree that this was not fully clear in the original manuscript and have now re-structured the Methods to separate the governing equations of the compartmental model from the personalization of the distributions.

Insert R3 Lines 128 - 166 New sections to separate governing equations from personalization of distributions.

Comment 4: The mathematical model is not clearly presented. The authors discuss how they arrived to the model, but then the set of equations to be solved (compartmental 0D models) are not clearly written. How are these differing from other models in literature? How is the model validated?

Response to comment 4

This is fair comment, and we have restructured the Methods to clarify this. The underlying compartmental model, based on mass balance, is longstanding, widely accepted and has been used by many investigators. Apart from details such as the number of compartments and the detailed form of the blood-gas dissociation curves, the model we used was essentially the same as that of Busana et al. The difference between the two papers is essentially how you personalize the distributions for individual patients.

The issues around validation in this area are much harder. We can show that a distribution is a candidate distribution for an individual, in the sense that it reproduces the patient’s arterial PCO2 and PO2. In general, however, there is always an infinite number of candidate distributions, whereas there can only be one physical distribution pertaining in the lungs. What does tend to be common amongst a set of candidate distributions are certain qualitative features, such as their overall width or the number of their peaks. Common between Busana et al and our manuscript are the extraordinarily wide distributions seen with the four patients in whom there are solutions.

Removed Original Lines 76 - 117 Old section of Overview of the method

Insert R3 Lines 90 - 126 New section of Overview to clarify the problems in the paper and steps of solving them.

Comment 5

The issue of mass conservation is introduced in the abstract, but then the discussion at the end of the paper fail to highlight the reason for which this is unlikely to hold. In addition, one may find hard to believe that a physical principle in classic mechanics like mass conservation does not hold in this context.

Response to comment 5

Sorry. This has been misunderstood. Our point was actually the other way around, namely a result that violates a fundamental principle of classic mechanics means there is something wrong with the assumptions that generated it (NOT the assumptions of classical mechanics), here the assumption of the shunt fraction value. We have re-written this point.

Change Original Lines 35 - 38 ‘Finally, we note that an assumption of the classical V̇/Q̇ mass balance equations is unlikely to hold at very low V̇/Q̇ under conditions of high inspired oxygen, and therefore these distributions are an unlikely cause of the observed blood gas values in the patients.’

To R3 Lines 35 - 37 ‘We consider that these wide distributions arise because the assumed value for shunt flow is too low in these patients, and we discuss possible reasons why the assumption relating to shunt flow fraction may break down in COVID-19 pneumonia. ’

Comment 6

The motivation to this work appears to come from drawbacks from a paper in literature by Busana et al., which is unpleased by the authors. I believe that, regardless of the pros and cons of the mentioned previous study, negative views of this work should be recast in a more constructive manner.

Response to Comment 6

Thank you. We are glad that you flagged this because it was not intended. Busana et al have obtained patient data during the pandemic in a manner that has been remarkably hard to do. They should be commended for it. We have checked and, if necessary, rephrased our references to the Busana et al paper in the manuscript.

Remove Original Lines 20 - 38 Old Abstract

Replace with R3 Lines 20 - 37 New Abstract.

Remove Original Lines 40 - 73 Old Introduction

Replace with R3 Lines 39 - 87 New Introduction.

Comment 7

Abstract, 21 (and Introduction). Rephrase the first part of the abstract. Motivations to this paper and its content should not move from negative views on previously appeared papers. “For no patient they did obtain accurate results”. Rather, try recasting the previous work in a positive manner.

Response to Comment 7

Agreed. We have re-written this.

Remove Orignial Line 25 - 26 ‘For no patient did they obtain an accurate solution.’

Change Original lines 34 - 35 ‘We conclude that the absence of accurate solutions in Busana et al. arose through a failure of their method.’

To R3 Lines 33 - 35 ‘These distributions were extremely wide and unlikely to be physically realisable, because they predict the maintenance of very large concentration gradients in regions of the lung where convection is slow.’

Comment 8

Abstract, 27. After accuracy of previous results is discussed, the goal of the paper is stated “to determine whether such solutions exist, and if so, to develop accurate method by which possible solutions can be identified”. What is the the analysis of solutions’ existence that is established in this paper? What does solution identification mean?

Response to Comment 8

Busana et al have assumed that the shunt flow fraction was proportional to the non-aerated lung fruction, and calculated this from CT imaging. Using this assumed shunt flow fraction as given by Busana et al (and the non-shunt fraction calculated from this by subtracting from cardiac output), we used the three-compartment model to investigate whether there exist V̇/Q̇ distributions for the non-shunt part of the lung that can produce the measured arterial PCO2 and PO2. (this is what we mean by solutions’ existence). This model’s theoretical importance is that for any real V̇/Q̇ distribution, no matter how complex, there always exists a corresponding three-compartment model that can exactly replicate the patient’s PaCO2 and PaO2. Using the well established three-compartment model one can calculate the maximum physiologically possible shunt fraction (Q̇s3CM) and the minimum physiologically possible non-shunt fraction (Q̇ns3CM) for each patient. For patient 1, uibthe assumption that shunt flow fraction was proportional to the non-aerated lung fruction cannot hold, as this non-shunt flow fraction by Busana et al (Q̇nsBM) is too low, lower than the minimum possible (Q̇ns3CM), to be able to support gas-exchange to produce the patient’s PCO2 and PO2: so no solution exists (no V/Q distribution) with this assumption. For the other patients, solutions are possible with this assumed shunt and non-shunt fraction (derived from imaging), but we wanted to find a method that provides more accurate solutions, i.e. V/Q distributions that produce arterial PCO2 and PO2 that are within the measurement error of the blood gas analyser (which we take as a maximum error of 1 mmHg) (this is what is meant by solution identification).

Comments 9, 10 and 11

Abstract, 30. What does it mean that “no solution was possible”; Abstract, 32. What does it mean “precise solution to the problem”? Abstract, 34. In which sense are solutions “exact”?

Response to Comments 9, 10 and 11

We have revised the abstract to address these issues. The meanings were:

No solution was possible: no parameterization of the model of V/Q distribution exists that can reproduce the arterial PCO2, and PO2. (This occurs for patient 1 where the specified total blood flow is simply too small to deliver the required gas exchange.)

Change Original Lines 30 - 31 ‘For one of the five patients, we demonstrated that no solution was possible.’

To R3 Line 29 - 31 ‘For the one patient in whom Busana et al. did not find solutions, we demonstrated that the assumed shunt flow fraction led to a non-shunt blood flow that was too low to support the required gas exchange.’

Precision of the solution: defined in terms of the residuals for the arterial PCO2 and PO2. This is the difference between the patient’s measured data and the predicted values from the model. We aim for a precision that is within that reasonably associated with the blood gas analyser.

Insert R3 Lines 31 - 33 ‘For the other four patients, we found precise solutions (prediction error < 1x10-3 mmHg for both PaCO2 and PaO2), with distributions qualitatively similar to those of Busana et al.’

Exact solution: we have removed this term because all solutions require a degree of numerical estimation.

Remove Orignal Line 34 ‘exact solutions’.

Comment 12

Abstract, 34-35. The statement is unclear. What is the purpose of the method that is failing? Performing numerical discretization of the mathematical model? Or performing data assimilation?

Response to Comment 12

The classical equations referred to here model convective transport of gases to and from well mixed compartments, and assume that diffusion can be neglected (apart from equilibration across the alveolar membrane). This assumption is reasonable under most conditions. However, the high inspired PO2 in these patients coupled with the extraordinarily wide V/Q ratios will create certain regions of the lung where convective tramsport in the gas phase is very slow, but at the same time where very large concentration gradients are predicted to persist. Under these conditions, we think the assumption that diffusion can be neglected breaks down and the model is no longer valid.

Change Original Lines 35 - 38 ‘Finally, we note that an assumption of the classical V̇/Q̇ mass balance equations is unlikely to hold at very low V̇/Q̇ under conditions of high inspired oxygen, and therefore these distributions are an unlikely cause of the observed blood gas values in the patients.’

To R3 Lines 35 - 37 ‘We consider that these wide distributions arise because the assumed value for shunt flow is too low in these patients, and we discuss possible reasons why the assumption relating to shunt flow fraction may break down in COVID-19 pneumonia. ’

Comment 13

Abstract, 36. What is the conclusions and the proposed remedy to the unlikely assumption made on mass conservation?

Response to Comment 13

See response to comment 5. Fundamentally, we think the shunt flow assumption is not sufficiently accurate.

Reviewer #2

Comment 1

The authors refer to the work of Busana et al in terms too competitive, providing definite statements on such a work, e.g.

“… they subsequently failed to find any accurate solutions for potential …”

“… result from the hypothesis of Busana et al. are unlikely to represent the true state of gas exchange in these severely ill COVID-19 patients.”

The authors should clearly state that their model is an extension of that of Busana et al, with an improvement in some sense of the results, acknowledging the fact that the Busana model is the starting point.

Response to comment 1

Sorry. We are glad the reviewer makes this point as it really wasn’t intended. Busana et al should be congratulated for managing to obtain these data during the course of the pandemic. We have checked the wording and changed where appropriate. We have also clarified that what we set out to achieve was an alternative approach to Busana et al’s multiple simulation approach that could provide a direct calculation of parameterisations that should reproduce a patient’s arterial PCO2 and PO2.

Remove Original Lines 33 - 34 ‘We conclude that the absence of accurate solutions in Busana et al. arose through a failure of their method.’

Remove Original Line 388 ‘they subsequently failed to find any accurate solutions for potential V̇/Q̇ distributions’ removed.

Change Original Lines 458 - 459 ‘In conclusion, the V̇/Q̇ distributions that result from the hypothesis of Busana et al. are unlikely to represent the true state of gas exchange in these severely ill COVID-19 patients.’

To R3 Lines 512 - 514 ‘In conclusion, the V̇/Q̇ distributions that arise when the shunt blood flow fraction is assumed proportional to the non-aerated lung fraction are unlikely to represent the true state of gas exchange in these severely ill COVID-19 patients.’

Change Original lines 397 - 398 ‘Why the approach of Busana et al. failed to deliver solutions very close to the patients’ arterial PCO2 and PO2 values is not entirely clear.’

To R3 Lines 453 - 454 ‘Why the approach of Busana et al. did not lead to solutions very close to the patients’ PaCO2 and PaO2 values is not entirely clear.’

Comment 2

Related to the previous point, the authors used too much strong statements about their results, e.g.:

“… we have demonstrated that no such distributions exist for their first …”

“… we have demonstrated that multiple, indeed infinite sets, of potential V̇/Q̇ distributions exist…”

It seems to me that the results of this paper are more reasonable than the ones found in Busana et al, but that there is no any validation, so I would avoid to use “demonstrate”.

Response to comment 2

We don’t completely agree with the reviewer here.

Busana et al found no possible solutions for their first patient. We use the three-compartment model to show that the postulated blood flow to the aerated lung is simply too low to support the gas exchange required – there is no solution to the problem (and therefore the starting assumptions concerning shunt flow have to be wrong).

For the second statement, the key word is ‘potential’ (or candidate) distributions because they do reproduce the patient’s arterial PCO2 and PO2. However, we completely agree with the reviewer re: validation and have adjusted the text accordingly.

Comment 3

Related to the previous point: The authors used the available data for the parameter calibration, but not for the validation, is this true? If yes, this should be clearly stated in the text

Response to comment 3

Yes, that is completely correct. Furthermore, we argue that the extraordinarily-wide distributions are unlikely to exist in these patients given their very high inspired PO2. Thus, if there were some way of validating these results experimentally, we would expect the validation to fail. We think the problem resides with the ‘shunt flow assumption’, as covered in the Discussion.

R3 Lines 481 - 483 ‘Turning from the methodology to the results, what is evident from our solutions for the V̇/Q̇ distributions from both the methods we employed (Fig. 2 and Fig. 4) is that the assumption that the shunt fraction is proportional to the fraction of non-ventilated lung (proposed by Busana et al) led to compartments with extremely low estimates for V̇/Q̇.’

Comment 4

Also the number of cases (5) is not enough to demonstrate anything. It is noticeable to have some data after 1 year from pandemic, but the authors should again change the tone of their sentences, without any definite answer. Their results in fact “seem to show that …. “

Moreover, if I well understood, the data were obtained by Busana et al and this is another reason why the authors should refer to this paper in different terms (see point 1)

Response to comment 4

Whilst we can demonstrate things as they apply to individual patients, we agree with the reviewer that 5 patients are too few from which to draw generalized conclusions in relation to the patient population as a whole. We have checked the manuscript to ensure any generalizations have that caveat clearly stated. We also agree with the second point (see our response to point 1).

Comment 5

Methods – Overview: The journal is read by scientists with different expertise, thus I suggest to better contextualize the physical processes and the method. For example: What are the compartments? What is the pure shunt and pure deadspace? Not all the readers are familiar with this.

Response to comment 5

This is a very fair comment. We have revised the manuscript to include those definitions, but also more generally, we now start the methods with a description of the compartmental model on which this study is based.

Insert R3 Lines 90 - 126 An overview section has been introduced into the methods.

Comment 6

Eqns (1) and (2): I am not sure that the authors explicitly give the expression of g. In any case, Eqn (2) is useless, is the same of (1)

Response to comment 6

No we don’t give an explicit expression for g. In this study, we use quite a detailed mathematical model of the blood, which involves the simultaneous solution of four non-linear equations for the plasma H+ concentration, the intra-erythrocytic H+ concentration, the permeant strong ion difference in the plasma and the permeant strong ion difference in the red cells. These values are then substituted into other equations to get the blood CO2 and O2 contents. If we try to set this all out here (apart from anything else, there are 50-100 chemical constants), it will serve to confuse rather than help. It is better just to give the reference here (O’Neil at al) so that the interested reader can follow it up. Other readers only need to know what it is doing in order to follow the paper.

We agree equation 2 was probably unnecessary – the only points we were trying to make were that the inverse function exists (i.e. the function is both injective and surjective) and that it is possible to use it in calculations.

Change Original lines 128 and 129 two equations

To R3 line 165 one equation.

Comment 7

Methods: the authors should summarize all the procedure with a final algorithm or better with a flowchart, highlighting:

- the input

- how could they be obtained (measures, assumptions, …)

- the output

- their clinical relevance

Response to comment 7

This is an excellent idea and we have now introduced a flowchart into the Methods section.

Insert R3 Figure 1 as a flowchart.

Comment 8

Figures 1 and 2: It seems to me that different behaviours are experienced by Patients 2,3 vs 4,5. Please comment on this.

Response to comment 8

There are indeed some quantitative differences, and of course the patients differ in their arterial blood gases and the level of inspired O2 that they are receiving (table 1). However, qualitatively the results are similar. They are all monotonic increasing functions and the solutions are all confined to exceptionally low values for V/Q.

Comment 9

Details on the numerical methods used to find solutions should be provided

Response to comment 9

We used the in-built equation solvers in Matlab (there is nothing particularly tricky about the solutions). We have added this point to the methods and referred to the particular solvers that were employed.

Insert R3 Lines 114 - 115 ‘Where numerical solutions were required, Matlab’s inbuilt solvers fsolve and fminbnd were used.’

Comment 10

The clinical relevance of the results should be discussed.

Response to comment 10

We have added a section in the Discussion about the results’ clinical relevance.

Insert R3 lines 439 - 452, and Insert R3 lines 471 - 480 to discuss clinical relevance.

Comment 11

Limitations and future perspective should be added

Response to comment 11

A section on limitations and future perspective has been added in the Discussion.

Insert R3 line 506 - 511 to discurss limitations and future perspectives.

Comment 12

Line 294 should be after the caption.

Response to comment 12

Done.

RESPONSE TO REVIEWERS (2nd REVISION)

Reviewer #1

The paper improved after a significant revision that partially incorporated the major and minor questions. I think the paper has merit, even if some major points persist and must be thoroughly addressed.

Comment 1

I am very confused by the use of the words “solution”, “model”, and “problem”. Mathematically speaking, a solution is a value, number, function, etc… that fulfill the conditions set by equations. Here, I find very hard to understand which are the equations to be solved (models and problems) and which variables are the solutions by reading through the text. Figure 1 is adding confusion rather than giving a clear picture of the problems/equations and solutions searched for. What is meaning that a “solution is not possible”? I also find very difficult to identify data and solutions (?) in the models.

Response to comment 1

Thank you – this is very helpful comment to guide further revision. We have added a paragraph at the beginning of the Methods to define the terms ‘solution’, ‘model’ and ‘problem’.

A solution is a set of paired values for ventilation and perfusion {Vi, Qi}, that will result in calculated values for arterial PCO2 and PO2 that, to within experimental error, match the measured values from the patient. We illustrate solutions in the figures. The meaning of a ‘solution is not possible’ is that, after applying constraints relating to the patient, there are no sets {Vi, ,Qi} that form a solution to the problem. This can arise if one or more of the constraints is wrong.

Insert R3 Lines 91 - 103 to define ‘solution’, ‘model’ and ‘problem’.

Comment 2

The concept of “distribution” should be introduced and carefully presented. If I understand correctly, this work revolves around the idea of calculating such distribution instead of a sort of “trial and error” approach by Busana et al., who explore the space of plausible parameters to identify a plausible combination of these ones. Can this distribution interpreted instead as a combination of values?

Response to comment 2

We have added a definition of distribution in the paragraph at the start of the Methods. Busana et al do not state what their parameters are, but basically their parameters are used to generate the ‘ V/Q distribution’, which is the set of paired values {Vi, Qi}. The number of paired values in this set can be varied. We explore the three-compartment model of the lung – which has three pairs of values in this set (and has a very important place in the development of theory around gas exchange in the lung), a four-compartment model of the lung, and a ‘multi’-compartment model of the lungs, where the number of Vi, Qi pairs is very much higher and where it is really being used as a computational approximation to a continuous distribution (where the pairs of values Vi, Qi in the set {Vi, Qi} would be infinite).

So the answer to your question is yes. The distribution is the set {Vi, Qi}.

Insert R3 Lines 91 - 103 to define ‘distribution’.

Comment 3

118: “conservation of matter”. Shouldn’t be conservation of mass instead? Here, we are not working in the framework of relativistic mechanics, but of classical mechanics.

Response to comment 3

We have changed this.

Change R1 line 118 ‘conservation of matter’

To R3 line 133 ‘conservation of mass’.

Comment 4: 150: Eq. (5). g is not defined, if not much later in the text. Similarly for other mathematical notation.

Response to comment 4

As indicated in the preceding paragraph, g is a function that represents the blood gas model of reference 7. To make this clearer, we have now added the reference in the sentence immediately preceding equation 5.

Change R1 lines 148 - 149 ‘The model is represented here by the vector function:’

To R3 lines 163 - 164 ‘The model described in [7] is represented here by the vector function g:’.

Comment 5

Equations are numbered in round brackets (XY). However, in the text they are referred to as Eq XY. Instead, bibliographic references are cited in round brackets (in place of more common squared brackets), which is adding confusion to the “Method” section.

Response to comment 5

We have revised the manuscript so that the citations now appear in the text in squared brackets.

Comment 6

356-365: are these part of the table caption?

Response to comment 6

Yes, that is correct.

Reviewer #2

It is hard to evaluate the changes made by the authors. They should clearly indicate in their answers the number of pages and lines where changes have been made and, possibly, indicate in colours such changes in the text.

Response to reviewer #2

Our apologies for this. We used the track changes feature to highlight all the text that had changed, but there was so much of it, and so much editing, that the end result was a bit of a mess. The changes are much clearer in this second revision.

Attachment

Submitted filename: R3_response.docx

Decision Letter 3

António M Lopes

5 Aug 2022

Identifying putative ventilation-perfusion distributions in COVID-19 pneumonia

PONE-D-21-23433R3

Dear Dr. Robbins,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org.

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

António M. Lopes, PhD

Academic Editor

PLOS ONE

Additional Editor Comments (optional):

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation.

Reviewer #2: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions?

The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented.

Reviewer #2: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #2: N/A

**********

4. Have the authors made all data underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #2: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English?

PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here.

Reviewer #2: Yes

**********

6. Review Comments to the Author

Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters)

Reviewer #2: The authors answered to all my issues.I suggest the paper for publication on the journal.

Best regards

**********

7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #2: No

**********

Acceptance letter

António M Lopes

19 Aug 2022

PONE-D-21-23433R3

Identifying putative ventilation-perfusion distributions in COVID-19 pneumonia

Dear Dr. Robbins:

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department.

If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org.

If we can help with anything else, please email us at plosone@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. António M. Lopes

Academic Editor

PLOS ONE

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Attachment

    Submitted filename: response_to_reviewers_par_17Dec_CLEAN.docx

    Attachment

    Submitted filename: response_to_reviewers_08032022.docx

    Attachment

    Submitted filename: R3_response.docx

    Data Availability Statement

    All relevant data are within the paper.


    Articles from PLoS ONE are provided here courtesy of PLOS

    RESOURCES